Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Annals of Botany|July 16, 2008
Detailed analysis of the expression of an alpha-gliadin promoter and the deposition of alpha-gliadin protein during wheat grain developmentT W J M Van Herpen, M Riley, C Sparks, et al.
ACS Nano|January 25, 2019
Indirect to Direct Gap Crossover in Two-Dimensional InSe Revealed by Angle-Resolved Photoemission SpectroscopyMatthew J Hamer, Johanna Zultak, Anastasia V Tyurnina, et al.
Frontiers in Aging Neuroscience|May 30, 2023
A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterationsScott P Allen, Afnan Al Sultan, Elaine Kabucho Kibirige, et al.
BMC Genomics|January 13, 2006
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopesTeun W J M van Herpen, Svetlana V Goryunova, Johanna van der Schoot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancerZ Rahman, J Kavanagh, R Champlin, et al.
Nature|July 17, 2019
Author Correction: Resonantly hybridized excitons in moiré superlattices in van der Waals heterostructuresEvgeny M Alexeev, David A Ruiz-Tijerina, Mark Danovich, et al.
Nature|March 8, 2019
Resonantly hybridized excitons in moiré superlattices in van der Waals heterostructuresEvgeny M Alexeev, David A Ruiz-Tijerina, Mark Danovich, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
The Lancet. Infectious Diseases|August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
The Lancet. Infectious Diseases|June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Pageof 20